BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 23.50
+0.40 (1.73%)
Oct 13, 2026, 12:32 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 1.55 billion as of October 12, 2026. It is the 22,637th most valuable company in the world and the 277th biggest in Sweden. Its market cap has decreased by 14.23% in one year.
Market Cap
1.55B
Enterprise Value
1.23B
Revenue
32.51M
Global Rank
Country Rank
#277 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2001, STO:BINV's market cap has increased from 1.20B to 1.55B, an increase of 28.35%. That is a compound annual growth rate of 0.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.55B | -20.07% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hansa Biopharma AB | 3.66B |
| Vicore Pharma Holding AB | 2.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Flerie AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |
| SynAct Pharma AB | 946.37M |